ThinkCyte, a biotechnology company pioneering novel artificial intelligence (AI)-based cell analysis and sorting instruments, ...

The supplemental new drug application is based on data from the Phase 2 LITESPARK-015 trial.

The U.S. Food and Drug Administration (FDA) has accepted for review Biologics License Applications (BLA) for AVT05, ...

Touchlight, a leader in synthetic DNA technology, has appointed Will Downie as a key adviser to support its mission of ...

Clinigen, a global specialist pharmaceutical services company, entered a strategic partnership with Tepsivo, a digital Pharmacovigilance (PV) services provider. As part of the partnership, Clinigen ...

ReiThera has inked a comprehensive Master Service Agreement (MSA) with SillaJen, which establishes ReiThera as the ...

The approval was based on results from the TROPION-Breast01 Phase III trial.

Since its creation by a team of pharmaceutical, cold-chain management and quality assurance experts in 2004, Sentry BioPharma ...

The goal is to treat familial dysautonomia patients with a single injection.

Neurocrine Biosciences Inc. has appointed Andrew Ratz, Ph.D. as Senior Vice President of Drug Development, Delivery and ...

Kincell Bio, a cell therapy development and manufacturing organization (CDMO), has appointed Mark R. Bamforth as Chief ...

Cormica, an expert in life sciences testing and consulting, has acquired Zwisler Laboratorium, a provider of laboratory ...